European Commissioner Joaquin Almunia gave his last speech as the EU’s competition chief on Thursday, speaking at a seminar in London.
Almunia reflected upon the Directive on Antitrust Damages Actions, describing the matter as “the most important legal initiative I have launched during my term.” The initiative, which the Commissioner said will be enacted in only a matter of days, facilitates victims of anticompetitive behavior in obtaining damages from antitrust violators.
The speech is fitting for the policymaker, as he noted that the topic of binding legislation for such compensation would be a priority during his confirmation hearings in January of 2010.
”In my view, it was just reasonable and fair that all victims of antitrust infringements, whether citizens or companies, could effectively exercise their rights thanks to the EU legislator,” Almunia said Wednesday.
The new directive marked both the first EU-level legislation in private competition enforcement as well as the first EU competition legislation adopted with full European Parliament participation, the Commissioner said.
Almunia will exit his post at the end of the month, wherein his predecessor, Margrethe Vestager, will take up the duties of competition chief.
Full content: Europa
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas